SIREN : 422678722
CLINITEX 62 is a French company founded 27 years ago, specialized in the sector Nettoyage courant des bâtiments. Based in TILLOY-LES-MOFFLAINES (62217), this company of category ETI shows in 2024 a revenue of 10.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 10 337 507 € | 9 291 798 € | 8 833 134 € | 9 142 212 € | 7 894 165 € | 7 266 474 € | 7 321 874 € |
| Net income | 223 886 € | 188 830 € | 296 548 € | 319 683 € | 297 577 € | 384 355 € | 205 412 € |
| EBITDA | 511 531 € | 428 667 € | 594 692 € | 532 489 € | 577 394 € | 752 550 € | 271 758 € |
| Net margin | 2.2% | 2.0% | 3.4% | 3.5% | 3.8% | 5.3% | 2.8% |
In 2024, CLINITEX 62 achieves revenue of 10.3 M€. Over the period 2019-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +7.1%. Vs 2023, growth of +11% (9.3 M€ -> 10.3 M€). After deducting consumption (532 k€), gross margin stands at 9.8 M€, i.e. a rate of 95%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 512 k€, representing 4.9% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 224 k€, i.e. 2.2% of revenue. This profit can be retained or distributed to shareholders.
10 337 507 €
9 805 437 €
511 531 €
392 440 €
223 886 €
4.9%
The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 3.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
2.104%
30.563%
3.381%
0.062
25.6%
In 2024, the debt ratio of CLINITEX 62 (2.10) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of CLINITEX 62 (30.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of CLINITEX 62 (0.06) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 112.18. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.0x. Danger: operating income does not cover interest charges, unsustainable situation.
112.177
0.039
In 2024, the liquidity ratio of CLINITEX 62 (112.18) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of CLINITEX 62 (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 49 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 52 days. Favorable situation: supplier credit is longer than customer credit by 3 days. Inventory turnover is 1 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. WCR is negative (-10 days): operations structurally generate cash. Notable WCR improvement over the period (-133%), freeing up cash.
-301 235 €
49 j
52 j
1 j
-10 j
Indicative estimate only : the number of comparable transactions in this sector is limited (29 transactions). This range of 1 019 402€ to 3 414 256€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 29 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare CLINITEX 62 with other companies in the same sector:
Voir toutes les statistiques du secteur Nettoyage courant des bâtiments
The revenue of CLINITEX 62 in 2024 is 10.3 M€.
Yes, CLINITEX 62 generated a net profit of 224 k€ in 2024.
The headquarters of CLINITEX 62 is located in TILLOY-LES-MOFFLAINES (62217), in the department Pas-de-Calais.
The tax return of CLINITEX 62 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CLINITEX 62 operates in the sector Nettoyage courant des bâtiments (NAF code 81.21Z). See the 'Sector positioning' section above to compare the company with its competitors.